Medical Oncology in Franklin, TN
3 verified medical oncology doctors in Franklin.
Medical oncologists diagnose and treat cancer, coordinating chemotherapy and other systemic cancer therapies.
NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.
Verify a license at the Tennessee Board of Medical Examiners
Dr. Ruth Lamar, MD
Medical Oncology
CMS Open Payments· $1,456 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$1,456
Total received
50
Transactions
28
Paying companies
Top paying companies
Among the 4,060 medical oncology doctors we've analyzed, about 60% received any industry payment (median $4,500 among those who did). This doctor's total ranks around the 63th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US medical oncology doctors.
Payments to Ruth Lamar do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Patrick Murphy, MD
Medical Oncology
CMS Open Payments· $1,547 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$1,547
Total received
57
Transactions
28
Paying companies
Top paying companies
Among the 4,060 medical oncology doctors we've analyzed, about 60% received any industry payment (median $4,500 among those who did). This doctor's total ranks around the 63th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US medical oncology doctors.
Payments to Patrick Murphy do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Stephen Cantrell, MD
Medical Oncology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.